Lawmakers vow bipartisanship on Medicare drug issue
Washington -- The Congressional debate over Medicare prescription drug coverage continued to simmer in May, although Rep. Bill Thomas (R, Calif.) and Sen. Ron Wyden (D, Ore.) attempted to stir things up with an announcement they will work together to develop a benefit.
Wyden, the co-sponsor of pending Medicare drug benefit legislation in the Senate, and Thomas, chair of the House Ways and Means Committee's subcommittee on health, said they had agreed to several key principles that must be in a drug benefit.
Those principles include making the benefit universal and voluntary, requiring drug companies to pay a "return on investment" fee to support the drug benefit when they profit on government-funded research, and directing the Dept. of Health and Human Services to oversee the benefit.
President Clinton, meanwhile, met with congressional Democratic leaders and urged them to remain unified so they can develop a bipartisan prescription drug benefit and improve the chances that such a benefit will pass the GOP-controlled Congress this year.
Back to top
Copyright 2000 American Medical Association. All rights reserved.